Prothena Files 8-K on Financial Condition and Operations
Ticker: PRTA · Form: 8-K · Filed: Feb 15, 2024 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K filing, financial condition, results of operations, corporate disclosure
TL;DR
**Prothena just filed an 8-K on its financial results, so keep an eye out for the actual numbers!**
AI Summary
Prothena Corporation Public Limited Company filed an 8-K on February 15, 2024, reporting on its results of operations and financial condition. The filing, with SEC File Number 001-35676, indicates that the earliest event reported also occurred on February 15, 2024. This current report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing signals that Prothena is providing updated financial information to the public, which is crucial for investors to assess the company's performance and make informed decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial condition and operations, not indicating any immediate high-risk event without the actual content.
Key Numbers
- 001-35676 — SEC File Number (Identifies the registrant's filing with the SEC.)
- 98-1111119 — IRS Number (Registrant's IRS identification number.)
Key Players & Entities
- PROTHENA CORP PUBLIC LTD CO (company) — registrant
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION (company) — regulatory body
- February 15, 2024 (date) — date of report and earliest event
- Ireland (company) — state of incorporation
- 001-35676 (dollar_amount) — SEC File Number
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is PROTHENA CORPORATION PUBLIC LIMITED COMPANY.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 15, 2024.
Under which sections of the Securities Exchange Act of 1934 was this report filed?
This report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What items of information are included in this 8-K filing?
The item information includes 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
Where is Prothena Corporation Public Limited Company incorporated?
Prothena Corporation Public Limited Company is incorporated in Ireland.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-02-15 16:09:11
Key Financial Figures
- $0.01 — Registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Select
Filing Documents
- prta-20240215.htm (8-K) — 31KB
- exhibit991q42023earningsre.htm (EX-99.1) — 121KB
- prothenargbfullcolora19a.jpg (GRAPHIC) — 15KB
- 0001559053-24-000003.txt ( ) — 318KB
- prta-20240215.xsd (EX-101.SCH) — 2KB
- prta-20240215_lab.xml (EX-101.LAB) — 25KB
- prta-20240215_pre.xml (EX-101.PRE) — 13KB
- prta-20240215_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. The information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically incorporate by reference the information furnished pursuant to Item 2.02 (including Exhibit 99.1) of this Current Report. On February 15, 2024, Prothena Corporation plc issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2023. A copy of that press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 99.1 Press Release dated February 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 15, 2024 PROTHENA CORPORATION PLC By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Financial Officer and Chief Strategy Officer